Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | TLR4 | O00206 | 10/20 | 0.34 |
| ▸ | SELP | P16109 | 4/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8579402 | 1.00 | BCHE (0.34) | BCHEACHETLR4SELPL3MBTL1 | |
| SCHEMBL9019205 | 1.00 | BCHE (0.34) | BCHEACHETLR4SELPL3MBTL1 | |
| SCHEMBL9521824 | 0.90 | TLR4 (0.37) | TLR4SELPL3MBTL1 | |
| SCHEMBL8579544 | 0.88 | TLR4 (0.35) | TLR4SELPL3MBTL1 | |
| SCHEMBL9019090 | 0.87 | TLR4 (0.43) | TLR4SELPL3MBTL1 | |
| SCHEMBL9019191 | 0.87 | TLR4 (0.43) | TLR4SELPL3MBTL1 | |
| SCHEMBL10610554 | 0.85 | TLR4 (0.42) | TLR4SELPL3MBTL1 | |
| SCHEMBL10610859 | 0.85 | TLR4 (0.42) | TLR4SELPL3MBTL1 | |
| SCHEMBL9019027 | 0.84 | TLR4 (0.36) | TLR4SELPL3MBTL1 | |
| SCHEMBL6807462 | 0.84 | L3MBTL1 (0.40) | BCHEACHETLR4SELPL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5792840-A | SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES | SANKYO COMPANY, LIMITED (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0437016-B1 | Lipid A analogues having immunoactivating and anti-tumour activity | SANKYO CO (JP) | 1996-05-01 | — | — | EP | disclosed |
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |